These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36958408)

  • 1. A novel lonidamine derivative targeting mitochondria to eliminate cancer stem cells by blocking glutamine metabolism.
    Wang Q; Li S; Xu C; Hua A; Wang C; Xiong Y; Deng Q; Chen X; Yang T; Wan J; Ding ZY; Zhang BX; Yang X; Li Z
    Pharmacol Res; 2023 Apr; 190():106740. PubMed ID: 36958408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine.
    Guo L; Shestov AA; Worth AJ; Nath K; Nelson DS; Leeper DB; Glickson JD; Blair IA
    J Biol Chem; 2016 Jan; 291(1):42-57. PubMed ID: 26521302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
    Ózsvári B; Sotgia F; Lisanti MP
    Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
    Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D
    EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
    Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
    Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reprogramming Cancer Stem-like Cells with Nanoforskolin Enhances the Efficacy of Paclitaxel in Targeting Breast Cancer.
    Singh D; Singh P; Pradhan A; Srivastava R; Sahoo SK
    ACS Appl Bio Mater; 2021 Apr; 4(4):3670-3685. PubMed ID: 35014452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salinomycin effectively eliminates cancer stem-like cells and obviates hepatic metastasis in uveal melanoma.
    Zhou J; Liu S; Wang Y; Dai W; Zou H; Wang S; Zhang J; Pan J
    Mol Cancer; 2019 Nov; 18(1):159. PubMed ID: 31718679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
    Seto K; Sakabe T; Itaba N; Azumi J; Oka H; Morimoto M; Umekita Y; Shiota G
    Anticancer Res; 2017 Jul; 37(7):3569-3579. PubMed ID: 28668848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An insight into the associations between microRNA expression and mitochondrial functions in cancer cell and cancer stem cell.
    Tan WL; Subha ST; Mohtarrudin N; Cheah YK
    Mol Biol Rep; 2023 Jun; 50(6):5395-5405. PubMed ID: 37074612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting glutamine metabolism and autophagy: the combination for prostate cancer radiosensitization.
    Mukha A; Kahya U; Dubrovska A
    Autophagy; 2021 Nov; 17(11):3879-3881. PubMed ID: 34486482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of antineoplastic activity of lonidamine.
    Nath K; Guo L; Nancolas B; Nelson DS; Shestov AA; Lee SC; Roman J; Zhou R; Leeper DB; Halestrap AP; Blair IA; Glickson JD
    Biochim Biophys Acta; 2016 Dec; 1866(2):151-162. PubMed ID: 27497601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
    Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
    J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyethyl starch stabilized copper-diethyldithiocarbamate nanocrystals for cancer therapy.
    Xiao C; Li J; Wang X; Li S; Xu C; Zhang Z; Hua A; Ding ZY; Zhang BX; Yang X; Li Z
    J Control Release; 2023 Apr; 356():288-305. PubMed ID: 36870542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial Fuel Dependence on Glutamine Drives Chemo-Resistance in the Cancer Stem Cells of Hepatocellular Carcinoma.
    Lee ACK; Lau PM; Kwan YW; Kong SK
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovatodiolide suppresses yes-associated protein 1-modulated cancer stem cell phenotypes in highly malignant hepatocellular carcinoma and sensitizes cancer cells to chemotherapy in vitro.
    Chang HL; Chen HA; Bamodu OA; Lee KF; Tzeng YM; Lee WH; Tsai JT
    Toxicol In Vitro; 2018 Sep; 51():74-82. PubMed ID: 29698666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Targeting of Glutaminolysis as a Novel Strategy to Combat Cancer Stem Cells.
    Kao TW; Chuang YC; Lee HL; Kuo CC; Shen YA
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
    Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
    Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets.
    Cipolleschi MG; Marzi I; Santini R; Fredducci D; Vinci MC; D'Amico M; Rovida E; Stivarou T; Torre E; Dello Sbarba P; Stecca B; Olivotto M
    Cell Cycle; 2014; 13(2):268-78. PubMed ID: 24200964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate.
    Cui J; Hollmén M; Li L; Chen Y; Proulx ST; Reker D; Schneider G; Detmar M
    Oncotarget; 2017 Jan; 8(1):1007-1022. PubMed ID: 27894093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties.
    Liu S; Sun Y; Hou Y; Yang L; Wan X; Qin Y; Liu Y; Wang R; Zhu P; Teng Y; Liu M
    J Hematol Oncol; 2021 Oct; 14(1):178. PubMed ID: 34715882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.